This was confirmed by STAT3 transcriptional activation ELISA, in which wild-type Tsc2(+/+) MEFs and TSC2(+) AML cells were treated with their corresponding TSC2-deficient cell conditioned media for 1 h, which strongly promoted STAT3 nuclear activation (Fig. 2c). This evidence concerns the gene STAT3 and acute myeloid leukemia.